These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16767568)

  • 21. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natural course of infection in children and familial transmission of C viral hepatitis].
    Matyla-Radzewska A; Wysocki J
    Przegl Epidemiol; 2005; 59(2):475-81. PubMed ID: 16190556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].
    Portilla J; López-Burgos A; Saiz-De-La-Hoya-Zamácola P; Sánchez-Payá J; Bedía-Collantes M; Faraco-Atienzar I; Lissen E
    Gastroenterol Hepatol; 2009; 32(6):387-94. PubMed ID: 19477553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
    Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
    J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
    Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
    J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current practice patterns of primary care physicians in the management of patients with hepatitis C.
    Shehab TM; Sonnad SS; Jeffries M; Gunaratnum N; Lok AS
    Hepatology; 1999 Sep; 30(3):794-800. PubMed ID: 10462388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study.
    Cadranel JF; Di Martino V; Lambrey G; Mourlhon C; Nalet B; Anciaux ML; Richard C; Bigué JP; Barjon JN; Bories C; Barbare JC; Halimi C; Ribière O; Eugène C; Pauwels A; Jeanne S; Donato L; Dumouchel P; Pariente A; Duverlie G; Devergie B; Arlot S; Capron D
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):829-36. PubMed ID: 18794595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
    J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
    Bayram A; Ozkur A; Erkilic S
    J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
    Teuber G; Schäfer A; Rimpel J; Paul K; Keicher C; Scheurlen M; Zeuzem S; Kraus MR
    J Hepatol; 2008 Dec; 49(6):923-9. PubMed ID: 18929420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schistosoma mansoni coinfection could have a protective effect against mixed cryoglobulinaemia in hepatitis C patients.
    Abbas OM; Omar NA; Zaghla HE; Faramawi MF
    Liver Int; 2009 Aug; 29(7):1065-70. PubMed ID: 19192170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.